WHO ICTRP trial
Effects of rosuvastatin and sevelamer in coronary calcification in chronic…
RBR-6pngwz · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Not Recruiting
Key facts
| Trial ID | RBR-6pngwz |
|---|---|
| Public title | Effects of rosuvastatin and sevelamer in coronary calcification in chronic kidney disease patients |
| Scientific title | Effects of rosuvastatin and sevelamer in coronary calcification in chronic kidney disease patients not on dialysis |
| Primary sponsor | UNIVERSIDADE FEDERAL DE SAO PAULO |
| Registry | Registro Brasileiro de Ensaios Clinicos (ReBEC) |
| Recruitment status | Not Recruiting |
| Study type | Intervention |
| Phase | 4 |
| Countries | Brazil |
| Conditions | Coronary calcification |
| Interventions | Group A - Rosuvastatin 10mg MID,for 12 months Group B - Sevelamer 800mg TID,for 12 months Group C - control (not using a special drug);drug |
| Registration date | Jul 20, 2011 |
| Registry page | ensaiosclinicos.gov.br |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: